Table 3 Disease phase, disease... | American Society of Hematology

Table 3

Disease phase, disease parameters, and patient-reported outcomes at baseline and follow-up

	Baseline			Follow-up			P
Disease phase, %
Chronic phase		98.2			99.4		NS
Accelerated phase		1.8			0.6
Blast crisis		0.0			0.0
Disease parameters (if available)*
Hematologic response, n		154			144		NS
Complete, %		95.5			94.4
No evidence of leukemia, %		4.5			2.8
Return to chronic phase, %		0.0			2.8
Cytogenetic response, n		129			110		NS
Complete, %		85.3			87.3
Major, %		7.0			6.4
Partial, %		7.8			6.4
Molecular response, n		104			96		NS
≥ 3 log, %		77.9			75.0
≥ 2 log, %		22.1			25.0
	Range	M	SD	Range	M	SD
Functional status / quality of life (scale of 8-42)†	14-42	31.5	6.5	16-42	32.3	6.5	NS
Quality of chronic care (scale of 1-5)	1-5	2.8	0.9	1-4.9	2.6	0.9	.01
Knowledge (scale of 0-100)	0-100	71.9	20.3	0-100	69.2	24.4	NS

	Baseline			Follow-up			P
Disease phase, %
Chronic phase		98.2			99.4		NS
Accelerated phase		1.8			0.6
Blast crisis		0.0			0.0
Disease parameters (if available)*
Hematologic response, n		154			144		NS
Complete, %		95.5			94.4
No evidence of leukemia, %		4.5			2.8
Return to chronic phase, %		0.0			2.8
Cytogenetic response, n		129			110		NS
Complete, %		85.3			87.3
Major, %		7.0			6.4
Partial, %		7.8			6.4
Molecular response, n		104			96		NS
≥ 3 log, %		77.9			75.0
≥ 2 log, %		22.1			25.0
	Range	M	SD	Range	M	SD
Functional status / quality of life (scale of 8-42)†	14-42	31.5	6.5	16-42	32.3	6.5	NS
Quality of chronic care (scale of 1-5)	1-5	2.8	0.9	1-4.9	2.6	0.9	.01
Knowledge (scale of 0-100)	0-100	71.9	20.3	0-100	69.2	24.4	NS

M indicates mean; SD, standard deviation; P, probability of test statistic for test comparing baseline and follow-up; n, subsample size; and NS, not significant.

Valid % shown, missing data not reported.

†

Nonstandardized scores.

View Large

This Feature Is Available To Subscribers Only